Goldman Sachs Group Inc Kura Oncology, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 709,484 shares of KURA stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
709,484
Previous 831,885 14.71%
Holding current value
$11.3 Million
Previous $17.1 Million 19.06%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$18.57 - $23.23 $2.27 Million - $2.84 Million
-122,401 Reduced 14.71%
709,484 $13.9 Million
Q2 2024

Aug 13, 2024
BUY
$17.53 - $22.98 $806,537 - $1.06 Million
46,009 Added 5.85%
831,885 $17.1 Million
Q1 2024

May 15, 2024
BUY
$13.42 - $23.53 $3.41 Million - $5.98 Million
254,314 Added 47.84%
785,876 $16.8 Million
Q4 2023

Feb 13, 2024
BUY
$7.58 - $14.38 $536,398 - $1.02 Million
70,765 Added 15.36%
531,562 $7.64 Million
Q3 2023

May 14, 2024
SELL
$8.44 - $11.86 $597,256 - $839,272
-70,765 Reduced 13.31%
460,797 $4.2 Million
Q3 2023

Nov 14, 2023
SELL
$8.44 - $11.86 $3.96 Million - $5.57 Million
-469,561 Reduced 50.47%
460,797 $4.2 Million
Q2 2023

May 14, 2024
SELL
$9.62 - $13.99 $1.5 Million - $2.19 Million
-156,442 Reduced 14.39%
930,358 $9.84 Million
Q2 2023

Aug 14, 2023
SELL
$9.62 - $13.99 $1.5 Million - $2.19 Million
-156,442 Reduced 14.39%
930,358 $9.84 Million
Q1 2023

May 14, 2024
SELL
$10.71 - $14.6 $650,000 - $886,088
-60,691 Reduced 5.29%
1,086,800 $13.3 Million
Q1 2023

May 11, 2023
SELL
$10.71 - $14.6 $650,000 - $886,088
-60,691 Reduced 5.29%
1,086,800 $13.3 Million
Q4 2022

May 14, 2024
SELL
$11.23 - $16.9 $3.24 Million - $4.87 Million
-288,301 Reduced 20.08%
1,147,491 $14.2 Million
Q4 2022

Feb 13, 2023
SELL
$11.23 - $16.9 $3.24 Million - $4.87 Million
-288,301 Reduced 20.08%
1,147,491 $14.2 Million
Q3 2022

May 14, 2024
BUY
$12.01 - $19.45 $5.65 Million - $9.16 Million
470,766 Added 48.78%
1,435,792 $19.6 Million
Q3 2022

Nov 10, 2022
BUY
$12.01 - $19.45 $5.65 Million - $9.16 Million
470,766 Added 48.78%
1,435,792 $19.6 Million
Q2 2022

May 14, 2024
BUY
$10.71 - $18.33 $4.64 Million - $7.95 Million
433,464 Added 81.55%
965,026 $17.7 Million
Q2 2022

Aug 15, 2022
BUY
$10.71 - $18.33 $5.18 Million - $8.87 Million
483,836 Added 100.55%
965,026 $17.7 Million
Q1 2022

May 16, 2022
BUY
$11.78 - $16.98 $2.06 Million - $2.97 Million
174,913 Added 57.11%
481,190 $7.74 Million
Q4 2021

Feb 14, 2022
BUY
$12.22 - $19.57 $300,123 - $480,639
24,560 Added 8.72%
306,277 $4.29 Million
Q3 2021

Nov 10, 2021
BUY
$15.42 - $21.72 $4.34 Million - $6.12 Million
281,717 New
281,717 $5.28 Million

Others Institutions Holding KURA

# of Institutions
185
Shares Held
81.8M
Call Options Held
42.1K
Put Options Held
34K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.06B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email